Separately, in a Federal Register notice published May 1, 2026 (docket FDA-2018-N-3240), FDA proposed NOT to add semaglutide, tirzepatide, or liraglutide to the 503B outsourcing-facility bulks list
documented BPC-157's protective effects against liver damage induced by diclofenac, ibuprofen, and other NSAIDs in rat models [1]
Staying hydrated and ensuring a balanced diet can help reduce these effects
For formulators seeking genuine differentiation in the antioxidant space, LiposoMax Glutathione offers clinical advantages that translate into real opportunities, both for human health and dietary supplement formulation
Use SPF 30+ daily, especially in NYC and Miami where UV exposure is high